SCYNEXIS INC — Director's Dealing 2017

Aug 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SCYNEXIS INC (SCYX)
CIK: 0001178253
Period of Report: 2017-08-11

Reporting Person: Angulo Gonzalez David (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-11	Common Stock	P	10000	$1.55	Acquired	72000	Direct